(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 547080
Date | Daily Closing Price | Open | High | Low | Volume |
19 Fri Apr 2024 | 86.85 | 88.45 | 89.90 | 84.62 | 1.486 times |
18 Thu Apr 2024 | 88.90 | 87.93 | 91.76 | 86.56 | 1.343 times |
17 Wed Apr 2024 | 88.38 | 87.31 | 89.69 | 86.77 | 1.331 times |
16 Tue Apr 2024 | 86.09 | 84.51 | 88.08 | 84.44 | 0.751 times |
15 Mon Apr 2024 | 85.18 | 87.18 | 87.84 | 84.33 | 0.925 times |
12 Fri Apr 2024 | 87.25 | 92.59 | 93.00 | 87.03 | 0.886 times |
11 Thu Apr 2024 | 92.25 | 91.47 | 92.56 | 90.44 | 0.739 times |
10 Wed Apr 2024 | 90.49 | 88.13 | 90.59 | 84.55 | 1.042 times |
09 Tue Apr 2024 | 92.20 | 92.27 | 93.93 | 91.34 | 1.299 times |
08 Mon Apr 2024 | 91.54 | 92.33 | 93.21 | 90.57 | 0.796 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 87.3, but if it comes above 87.3, then a intra day buy could be more profitable.
If you take a sell trade below 87.3, then use 87.3 as stoploss and 83.7 as target. However if you take a buy trade in stock , then use 87.3 as stoploss and 90.31 as target.
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 68.28 |
Downside Target | 72.24 |
Downside Target | 75.20 |
Downside Target | 84.33 |
Downside Target | 86.76 |
Upside Target | 91.76 |
Upside Target | 93.93 |
Upside Target | 94.00 |
Upside Target | 95.98 |
Upside Target | 97.00 |
Upside Target | 98.06 |
Upside Target | 101.00 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 83.53 |
Downside Intraday Target | 80.22 |
Upside Intraday Target | 90.96 |
Upside Intraday Target | 95.08 |
Upside Intraday Target | 87.65 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
19 Fri Apr 2024 | 86.85 | 87.18 | 91.76 | 84.33 | 1.226 times |
12 Fri Apr 2024 | 87.25 | 92.33 | 93.93 | 84.55 | 0.886 times |
05 Fri Apr 2024 | 91.65 | 95.00 | 97.00 | 88.23 | 1.258 times |
28 Thu Mar 2024 | 94.86 | 87.59 | 95.98 | 86.76 | 0.422 times |
22 Fri Mar 2024 | 87.04 | 90.86 | 91.81 | 84.81 | 1.625 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
19 Fri Apr 2024 | 86.85 | 95.00 | 97.00 | 84.33 | 0.539 times |
28 Thu Mar 2024 | 94.86 | 93.81 | 98.06 | 84.81 | 0.82 times |
29 Thu Feb 2024 | 93.52 | 79.33 | 101.00 | 72.24 | 1.428 times |
31 Wed Jan 2024 | 79.53 | 90.54 | 93.07 | 75.20 | 0.637 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 88.88 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 88.88 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.